PTA BALLOON CATHETER MARKET ANALYSIS

PTA Balloon Catheter Market, by Material Type (Polyurethane, Nylon), by Application (Coronary Artery Disease and Peripheral Vascular Disease), by End User (Hospitals, Ambulatory Surgical Centers, and Others(Specialist Clinics)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Sep 2022
Code : CMI2815
Pages :178
Formats :
Excel and PDF
Industry : Medical Devices

Market News

Global PTA Balloon Catheter Market: Key Developments

The government authorities such as the U.S. Food and Drug Administration, European Commission, and others provide approval for the PTA balloon catheter products in respective regions.

For instance, Surmodics, Inc., a medical device company received the U.S. Food and Drug Administration (FDA) 510(k) and CE Mark clearance for its .014” low-profile percutaneous transluminal angioplasty (PTA) balloon dilation catheter in April 2018.

Furthermore, in September 2021, Medtronic plc. ,a medical device company, announced the CE mark approval and the European launch of the 200mm and 250mm IN.PACT Admiral drug-coated balloons (DCBs). The product is intended to treat long complex femoropopliteal lesions efficiently in patients with peripheral arterial disease.